Home › Research › Down syndrome and Alzheimer's
Life Stress and Dementia Risk in Adults with Down Syndrome
Alexandra Linker, Sigan L. Hartley, Shahid H. Zaman, Luciana Mascarenhas Fonseca. Innovation in Aging, 2025-12-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Abstract Down syndrome (DS) is the most common genetic cause of intellectual disability, resulting from a triplication of chromosome 21. Individuals with DS are at a higher risk of developing Alzheimer’s Disease (AD) compared to the general population. Previously, exposure to stress has been suggested as a risk factor for dementia and AD in the general population. However, the role of life stress in the timing of AD in DS is underinvestigated. Using the Alzheimer Biomarkers Consortium - Down Syndrome (ABC-DS) dataset, we analyzed the association between baseline life stressors, and later cognitive decline and dementia at 16 or 32-month follow-up. We found that a higher baseline sum of stress events was associated with greater risk of conversion from baseline stable cognition to mild cognitive impairment (MCI) or dementia at follow up, even when controlling for age, sex, premorbid level of intellectual disability, site, clinical latency between assessments, and the presence of anxiety or depression (odds ratio = 1.53, p = 0.021). Additionally, the death of a loved one at baseline, when rated as having a negative or complex impact, was associated with a decline of more than 6 points on the Block Design test (p = 0.009), compared to those without this experience. These results suggest that life stressors may predict cognitive decline and dementia in adults with DS, highlighting a potential target for treatment or intervention. Results also suggest that there may be similar risk factors for AD in adults with DS as those found in the general population.
What this study adds
Evidence grade: Low
In adults with Down syndrome, a higher number of life stressors at baseline was linked to a greater risk of progressing to mild cognitive impairment or dementia at follow-up. The findings suggest that life stress may predict cognitive decline in this group, though the study does not prove that stress causes dementia.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Linker, A., Hartley, S. L., Zaman, S. H., & Fonseca, L. M. (2025). Life Stress and Dementia Risk in Adults with Down Syndrome. Innovation in Aging. https://doi.org/10.1093/geroni/igaf122.3619
Vancouver
Linker A, Hartley SL, Zaman SH, Fonseca LM. Life Stress and Dementia Risk in Adults with Down Syndrome. Innovation in Aging. 2025. doi:10.1093/geroni/igaf122.3619.
BibTeX
@article{linker2025-0b6c1de8,
author = {Linker, Alexandra and Hartley, Sigan L. and Zaman, Shahid H. and Fonseca, Luciana Mascarenhas},
title = {{Life Stress and Dementia Risk in Adults with Down Syndrome}},
journal = {Innovation in Aging},
year = {2025},
doi = {10.1093/geroni/igaf122.3619},
url = {https://doi.org/10.1093/geroni/igaf122.3619}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Individuals with DS are at a higher risk of developing Alzheimer’s Disease (AD) compared to the general population.
- We found that a higher baseline sum of stress events was associated with greater risk of conversion from baseline stable cognition to mild cognitive impairment (MCI) or dementia at follow up, even when controlling for age, sex, premorbid level of intellectual disability, site, clinical latency between assessments, and the presence of anxiety or depression (odds ratio = 1.53, p = 0.021).
- Additionally, the death of a loved one at baseline, when rated as having a negative or complex impact, was associated with a decline of more than 6 points on the Block Design test (p = 0.009), compared to those without this experience.
- These results suggest that life stressors may predict cognitive decline and dementia in adults with DS, highlighting a potential target for treatment or intervention.
- Results also suggest that there may be similar risk factors for AD in adults with DS as those found in the general population.
Why it matters
In adults with Down syndrome, a higher number of life stressors at baseline was linked to a greater risk of progressing to mild cognitive impairment or dementia at follow-up. The findings suggest that life stress may predict cognitive decline in this group, though the study does not prove that stress causes dementia.
Study details
- Evidence strengthLow
How this study scored 30/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Innovation in Aging) |
| Journal's citation record | 0 / 4 | Innovation in Aging: journal h-index 48 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Luciana Mascarenhas Fonseca: h-index 16 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Cambridge: institution h-index 1,973 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 2 countries |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 2 / 2 | Free to read |
| Total | 30 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.